Key Takeaways
- Recurrence reduction: Adding otoendoscopy to microscopic surgery with Facial Nerve (FN) monitoring lowered cholesteatoma recurrence to 5.71% (2/35) versus 25.71% (9/35) for microscopy + monitoring and 26.47% (9/34) for microscopy alone (P=0.05).
- Operative efficiency: The dual-endoscope + monitoring group had the shortest operative time at 115.34 ± 11.87 min, versus 121.71 ± 13.32 min (microscopy + monitoring) and 130.56 ± 19.97 min (microscopy alone) (P<0.001).
- Facial nerve safety: Only 1 case of transient facial palsy occurred, in the microscopy-only group; no permanent Facial Nerve (FN) injury was observed across 104 patients.
- Hearing outcomes: Mean air-conduction thresholds and air-bone gaps improved significantly in all three groups at 3 months postoperatively (P<0.001), with no significant between-group differences.
Clinical Context
Middle ear cholesteatoma surgery demands two competing priorities: complete eradication of disease to prevent recurrence and preservation of the Facial Nerve (FN), whose horizontal segment frequently exhibits bony dehiscence. Reported rates of facial palsy following otologic surgery range from 0.6% to 3.6%. Conventional microscopic approaches are constrained by a linear line-of-sight, limiting exposure of the epitympanum and posterior tympanum and leaving residual cholesteatoma matrix behind.
Otoendoscopy offers wide-angle, high-resolution, multi-angled visualization that reaches recesses inaccessible to the microscope—the anterior epitympanic recess, posterior tympanum, and peristapedial region. Combining both optical systems allows surgeons to exploit the microscope for wide-field mastoid work and the endoscope for close-range, angled inspection and clearance. Concurrently, Intraoperative Neurophysiological Monitoring (IONM) of the Facial Nerve enables rapid nerve identification and real-time warning during dissection near the nerve, reducing iatrogenic injury and the time spent searching for the nerve.
This study from a high-volume tertiary surgical center (Department of Otorhinolaryngology-Head and Neck Surgery, Yibin First People's Hospital) evaluated whether dual-endoscope surgery combined with FN monitoring improves operative efficiency and recurrence outcomes compared with microscopy with or without monitoring.
Clinical Evidence & Cohort Breakdown
A total of 104 patients with middle ear cholesteatoma requiring surgery (January 2018 – May 2022) were randomized into three groups. All procedures were performed by a single surgeon, with follow-up of 18–36 months. Inclusion required cholesteatoma confined to the tympanum, antrum, and partial mastoid on CT, confirmed by pathology, with conductive or mixed hearing loss and no significant facial nerve canal or semicircular canal destruction. Patients with prior ear surgery, sensorineural hearing loss, preoperative facial palsy or vertigo, or loss to follow-up were excluded.
| Parameter | Dual-Endoscope + FN Monitoring (n=35) | Microscopy + FN Monitoring (n=35) | Microscopy Alone (n=34) | F (χ²) | P |
|---|---|---|---|---|---|
| Age (mean ± SD, years) | 42.14 ± 9.77 | 40.51 ± 7.83 | 43.59 ± 10.89 | 0.89 | 0.41 |
| Sex (male/female) | 21/14 | 17/18 | 17/17 | (1.09) | 0.58 |
| Operative time (mean ± SD, min) | 115.34 ± 11.87 | 121.71 ± 13.32 | 130.56 ± 19.97 | 8.47 | <0.001 |
| Dry ear at 1 month [n (%)] | 30 (85.7%) | 21 (60.0%) | 21 (61.7%) | (6.75) | 0.03 |
| Tympanic membrane perforation [n (%)] | 4 (11.4%) | 3 (8.6%) | 5 (14.7%) | (0.64) | 0.73 |
| Cholesteatoma recurrence [n (%)] | 2 (5.71%) | 9 (25.71%) | 9 (26.47%) | (6.21) | 0.05 |
| Bone-conduction threshold, preop (mean ± SD, dB HL) | 24.74 ± 9.37 | 23.17 ± 7.83 | 24.94 ± 10.98 | 0.37 | 0.70 |
| Bone-conduction threshold, 3 mo postop (mean ± SD, dB HL) | 24.63 ± 9.51 | 24.37 ± 7.91 | 25.47 ± 9.56 | 0.14 | 0.87 |
| Air-conduction threshold, preop (mean ± SD, dB HL) | 51.66 ± 8.88 | 50.60 ± 7.16 | 52.09 ± 10.34 | 0.26 | 0.77 |
| Air-conduction threshold, 3 mo postop (mean ± SD, dB HL) | 36.86 ± 8.06 | 36.54 ± 6.37 | 37.26 ± 9.50 | 0.07 | 0.93 |
| Air-bone gap, preop (mean ± SD, dB HL) | 26.91 ± 3.43 | 27.43 ± 3.52 | 27.15 ± 3.62 | 0.19 | 0.83 |
| Air-bone gap, 3 mo postop (mean ± SD, dB HL) | 12.46 ± 4.93 | 12.17 ± 4.84 | 11.79 ± 3.72 | 0.19 | 0.83 |
Postoperative air-conduction thresholds and air-bone gaps decreased significantly versus preoperative values in all groups (P<0.001). Ossicular chain reconstruction was performed with a total ossicular replacement prosthesis in 12 cases, a partial ossicular replacement prosthesis in 37 cases, and autologous bone in the remainder. Pairwise Z-testing confirmed the dual-endoscope + monitoring group had a significantly lower recurrence rate than each of the other two groups, while no difference existed between the microscopy + monitoring and microscopy-alone groups.
Intraoperative IONM Protocol & Technical Pearls
- Anesthesia setup: Induce with intravenous midazolam 2–3 mg, sufentanil 0.5 μg/kg, and propofol 2 mg/kg, then intubate after rocuronium 0.8 mg/kg. Minimize and monitor Neuromuscular Blockade (NMB) Residual, as residual blockade suppresses EMG Amplitude (μV) and can produce False-Positive LOS.
- Electrode placement: Position subdermal needle recording electrodes over the ipsilateral orbicularis oculi and orbicularis oris. Place the ground electrode subcutaneously at the sternum and the anodal (positive) lead of the stimulating probe subcutaneously at the ipsilateral shoulder.
- System configuration: Use the Medtronic NIM-Response 3.0 system. Confirm impedance and free-running EMG baseline before incision.
- Stimulation parameters: Use a Monopolar Stimulating Probe with a Stimulation Current (mA) range of 0.1–0.75 mA for Facial Nerve mapping. Direct contact with the nerve surface produces an audible "buzz" synchronized with the stimulus, confirming localization.
- Microscope phase: Perform standard postauricular incision and complete mastoidectomy with skeletonization under the microscope (Leica F40), exposing the lesion and defining the FN course with monitoring guidance.
- Endoscope phase: Introduce 0° and 30° otoendoscopes (STORZ, 14 cm length, 2.7 mm diameter) to visualize the posterolateral margin of the cholesteatoma and inspect the epitympanum, posterior tympanum, and peristapedial recesses. Use monitoring continuously while dissecting near the FN, chorda tympani, and ossicular chain.
- Clearance and reconstruction: Remove the cholesteatoma completely, including matrix; extract the ossicles if invaded. Reconstruct epitympanic and posterior canal wall defects with tragal cartilage, pack the tympanum and antrum with gelatin sponge, reposition the canal flap, and close.
- Ossiculoplasty: Reconstruct an interrupted ossicular chain with autologous bone or a partial/total ossicular replacement prosthesis as dictated by the defect.
Clinical Implications for Surgeons & IONM Specialists
- Dual-modality visualization addresses the recurrence driver: The significant recurrence reduction (5.71% vs ~26%) reflects the endoscope's ability to clear cholesteatoma matrix from recesses the microscope cannot see—the anterior epitympanic recess, posterior tympanum, and around the stapes—while preserving the canal wall and minimizing bony drilling.
- IONM shortens the nerve-search interval: The operative time advantage of monitored groups over microscopy alone supports FN monitoring as a time-saving adjunct, not merely a safety layer; the audible mapping signal accelerates nerve identification.
- Safety profile is favorable but not a substitute for technique: With only one transient palsy in the unmonitored group and none in monitored groups, IONM functions as an early-warning system during dissection near a dehiscent horizontal segment—particularly valuable when endoscopic angles bring the surgeon close to the nerve.
- Hearing outcomes are equivalent: Comparable air-bone gap closure across groups indicates that adding endoscopy and monitoring does not compromise acoustic reconstruction.
- Practical caveat: Endoscope use requires a second operator or scope-holder and adds setup time; the net operative-time benefit observed here depends on an experienced team and integrated monitoring workflow.
Reference
Wang J, Huang Y, Luo X, Long Y, Liu M, Guo D, Gong L, Zou S, Chen X. Clinical application of dual-endoscope combination with facial nerve monitoring in middle ear cholesteatoma surgery. Chinese Archives of Otolaryngology-Head and Neck Surgery. 2025;32(1):51–53. DOI: 10.16066/j.1672-7002.2025.01.011.
Medical Disclaimer: This article is provided for informational and educational purposes only and does not constitute medical advice. Clinical decisions regarding surgical technique, Intraoperative Neurophysiological Monitoring (IONM) protocols, and patient management should be made by qualified healthcare professionals based on individual patient circumstances and institutional guidelines.